COVID-19 Project ECHO in Nursing Homes

NCT04499391 | Completed Results

• 1 other identifier: PCORI Nursing Homes
• Study Type: interventional
• Target: 136
• Locations: 1 country
• Sites: 1

Brief Summary

Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setting. However, little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidence-based telehealth model, to connect Penn State University experts with remote nursing home staff and administrators to proactively support evidence-based infection control guideline implementation. Our study seeks to answer the critical research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes

Conditions

Covid19

Keywords

Project ECHO; telehealth

Outcome Measures

Primary Outcomes (1)

• Infection Rate

  Rate of COVID-19 infection in enrolled nursing homes, as measured by the cumulative 4-week incidence at study points for Confirmed COVID-19 cases per 1,000 residents

  Baseline, 4, 6, 12, 18 months

Secondary Outcomes (3)

• Hospitalization

  Baseline, 4, 6, 12, 18 months

• Death

  Baseline, 4, 6, 12, 18 months

• Flu-like Illness

  Baseline, 4, 6, 12, 18 months

Study Arms (2)

ECHO plus

EXPERIMENTAL

Nursing homes in this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. Sessions will be 90 minutes in duration and held weekly for 6 months (25 sessions total) at regularly scheduled times. Participants in this arm will receive a 2 month (8 sessions total) refresher course in Fall 2021. Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation

Other: Project ECHO

ECHO

ACTIVE COMPARATOR

Nursing homes in this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. Sessions will be 90 minutes in duration and held weekly for 6 months (25 sessions total) at regularly scheduled times. Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation

Other: Project ECHO

Interventions

Project ECHO OTHER

Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation. This differentiates ECHO from traditional learning and facilitates rapid dissemination of medical knowledge and increased capacity to deliver best-practice care.studying innovative approaches.

ECHO; ECHO plus

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

Sponsors & Collaborators

• Milton S. Hershey Medical Center: lead

Study Sites (1)

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

Related Publications (2)

• D'Souza GC, Kraschnewski JL, Francis E, Heilbrunn E, Kong L, Lehman E, Osevala N, Urso J, Chamberlain L, Suda KM, McNeil L, Calo WA. Implementation of COVID-19 infection control best practices in nursing homes amid the pandemic. BMC Health Serv Res. 2024 Aug 17;24(1):941. doi: 10.1186/s12913-024-11407-z.

  PMID: 39154191 DERIVED

• Calo WA, Francis E, Kong L, Hogentogler R, Heilbrunn E, Fisher A, Hood N, Kraschnewski J. Implementing Infection Control and Quality of Life Best Practices in Nursing Homes With Project ECHO: Protocol for a Patient-Centered Randomized Controlled Trial. JMIR Res Protoc. 2022 May 13;11(5):e34480. doi: 10.2196/34480.

  PMID: 35476823 DERIVED

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Results Point of Contact

• Title: Dr. Jennifer Kraschnewski
• Organization: Penn State College of Medicine

jkraschnewski@pennstatehealth.psu.edu

717-531-8161

Study Officials

• Jennifer Kraschnewski

  Penn State College of Medicine

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor and Vice Chair for Research, Department of Medicine

Model Details: stratified cluster randomized design

Study Record Dates

• First Submitted: July 31, 2020
• First Posted: August 5, 2020
• Study Start: December 4, 2020
• Primary Completion: September 27, 2022
• Study Completion: October 30, 2022
• Last Updated: August 22, 2024
• Results First Posted: August 22, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)